Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Call for coordinated antimicrobial approach at veterinary diagnostic laboratories.

Allerton F, Fishwick J, Paterson S, Weller R, Battersby I, Doyle R, Gould D, Caddy S, Dunning M, Featherstone HJ, Hardy J, Kent A, Pedro B, Smith K, Swinbourne F, Harris J, Heinrich C, Lau-Gillard P, Loeffler A, Maddinson R, Mason C, Ramsey I, Ridyard A, Robin L, Scudder C, Seth M, Tappin S, Singleton D, Smith H, Southerden P, Warland J, Whitehead M, Williams J.

Vet Rec. 2019 Jun 29;184(26):805-806. doi: 10.1136/vr.l4383. No abstract available.

PMID:
31249126
2.

Cardiac Rehabilitation Use After Percutaneous Coronary Intervention.

Sukul D, Seth M, Barnes GD, Dupree JM, Syrjamaki JD, Dixon SR, Madder RD, Lee D, Gurm HS.

J Am Coll Cardiol. 2019 Jun 25;73(24):3148-3152. doi: 10.1016/j.jacc.2019.03.515. No abstract available.

PMID:
31221264
3.

Clinical and Clinicopathological Features in Dogs with Uncomplicated Spontaneous Hyperadrenocorticism Diagnosed in Primary Care Practice (2013-2014).

Bennaim M, Centola S, Ramsey I, Seth M.

J Am Anim Hosp Assoc. 2019 Jul/Aug;55(4):178-186. doi: 10.5326/JAAHA-MS-6789. Epub 2019 May 17.

PMID:
31099602
4.

Association between ultrasonographic appearance of urine and urinalysis in dogs and cats.

Valls Sanchez F, Puig J, Olivares G, Holloway A, Seth M.

J Small Anim Pract. 2019 Jun;60(6):361-366. doi: 10.1111/jsap.12996. Epub 2019 Mar 13.

PMID:
30868599
5.

Benefits of Beta-Blockade in Sepsis and Septic Shock: A Systematic Review.

Lee YR, Seth MS, Soney D, Dai H.

Clin Drug Investig. 2019 May;39(5):429-440. doi: 10.1007/s40261-019-00762-z.

PMID:
30848423
6.

Prevalence of iatrogenic hypothyroidism in hyperthyroid cats treated with radioiodine using an individualised scoring system.

Fernandez Y, Puig J, Powell R, Seth M.

J Feline Med Surg. 2019 Jan 22:1098612X18822396. doi: 10.1177/1098612X18822396. [Epub ahead of print]

PMID:
30667287
7.

Drivers of Variation in 90-Day Episode Payments After Percutaneous Coronary Intervention.

Sukul D, Seth M, Dupree JM, Syrjamaki JD, Ryan AM, Nallamothu BK, Gurm HS.

Circ Cardiovasc Interv. 2019 Jan;12(1):e006928. doi: 10.1161/CIRCINTERVENTIONS.118.006928.

PMID:
30608883
8.

Pre-hospital Transport Times and Outcomes After Different Reperfusion Strategies for ST-Elevation Myocardial Infarction.

Andersson HB, Seth M, Gurm HS, Bates ER.

Am J Cardiol. 2019 Feb 1;123(3):375-381. doi: 10.1016/j.amjcard.2018.10.015. Epub 2018 Oct 21.

PMID:
30545480
9.

Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.

Gurm HS, Seth M, Dixon SR, Michael Grossman P, Sukul D, Lalonde T, Cannon L, West D, Madder RD, Adam Lauver D.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):222-230. doi: 10.1002/ccd.27819. Epub 2018 Aug 25.

PMID:
30144337
10.

Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Song C, Sukul D, Seth M, Wohns D, Dixon SR, Slocum NK, Gurm HS.

Circ Cardiovasc Interv. 2018 Jun;11(6):e006400. doi: 10.1161/CIRCINTERVENTIONS.118.006400.

PMID:
29895601
11.

Exploring the Healthcare Value of Percutaneous Coronary Intervention: Appropriateness, Outcomes, and Costs in Michigan Hospitals.

Alyesh DM, Seth M, Miller DC, Dupree JM, Syrjamaki J, Sukul D, Dixon S, Kerr EA, Gurm HS, Nallamothu BK.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004328. doi: 10.1161/CIRCOUTCOMES.117.004328.

PMID:
29853465
12.

ZNFX-1 Functions within Perinuclear Nuage to Balance Epigenetic Signals.

Ishidate T, Ozturk AR, Durning DJ, Sharma R, Shen EZ, Chen H, Seth M, Shirayama M, Mello CC.

Mol Cell. 2018 May 17;70(4):639-649.e6. doi: 10.1016/j.molcel.2018.04.009.

13.

Trends in Contrast Volume Use and Incidence of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2).

Gurm HS, Seth M, Dixon S, Kraft P, Jensen A.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):509-511. doi: 10.1016/j.jcin.2017.10.018. No abstract available.

14.

Association Between Medicaid Expansion and Cardiovascular Interventions in Michigan.

Likosky DS, Sukul D, Seth M, He C, Gurm HS, Prager RL.

J Am Coll Cardiol. 2018 Mar 6;71(9):1050-1051. doi: 10.1016/j.jacc.2017.12.044. No abstract available.

15.

Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.

Sukul D, Bhatt DL, Seth M, Zakroysky P, Wojdyla D, Rumsfeld JS, Wang T, Rao SV, Gurm HS.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):342-350. doi: 10.1016/j.jcin.2017.10.042. Epub 2017 Nov 12.

16.

A Sex Chromosome piRNA Promotes Robust Dosage Compensation and Sex Determination in C. elegans.

Tang W, Seth M, Tu S, Shen EZ, Li Q, Shirayama M, Weng Z, Mello CC.

Dev Cell. 2018 Mar 26;44(6):762-770.e3. doi: 10.1016/j.devcel.2018.01.025. Epub 2018 Feb 15.

17.

The Coding Regions of Germline mRNAs Confer Sensitivity to Argonaute Regulation in C. elegans.

Seth M, Shirayama M, Tang W, Shen EZ, Tu S, Lee HC, Weng Z, Mello CC.

Cell Rep. 2018 Feb 27;22(9):2254-2264. doi: 10.1016/j.celrep.2018.02.009. Epub 2018 Feb 15.

18.

Feline primary erythrocytosis: a multicentre case series of 18 cats.

Darcy H, Simpson K, Gajanayake I, Seth M, McGrotty Y, Szladovits B, Glanemann B.

J Feline Med Surg. 2018 Dec;20(12):1192-1198. doi: 10.1177/1098612X17750333. Epub 2018 Jan 24.

PMID:
29364032
19.

Primary percutaneous coronary intervention at centers with and without on-site surgical support: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Afana M, Gurm HS, Seth M, Frazier KM, Fielding S, Koenig GC.

Am Heart J. 2018 Jan;195:99-107. doi: 10.1016/j.ahj.2017.10.004. Epub 2017 Oct 14.

PMID:
29224652
20.

Membrane-like structure in the urinary bladder neck of a young cat: diagnosis and treatment using balloon dilatation and a balloon-expandable metallic stent.

Ruiz-Drebing M, Yap F, Seth M, Dennis R, Dominguez E.

JFMS Open Rep. 2017 Oct 6;3(2):2055116917733641. doi: 10.1177/2055116917733641. eCollection 2017 Jul-Dec.

21.

Right Ventricular Pacing Increases Risk of Appropriate Implantable Cardioverter-Defibrillator Shocks Asymmetrically: An Analysis of the ALTITUDE Database.

Cronin EM, Jones P, Seth MC, Varma N.

Circ Arrhythm Electrophysiol. 2017 Oct;10(10). pii: e004711. doi: 10.1161/CIRCEP.116.004711.

PMID:
29030379
22.

Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium).

Song C, Sukul D, Seth M, Dupree JM, Khandelwal A, Dixon SR, Wohns D, LaLonde T, Gurm HS.

Am J Cardiol. 2017 Dec 1;120(11):1926-1932. doi: 10.1016/j.amjcard.2017.08.009. Epub 2017 Aug 30.

PMID:
29025684
23.

The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Sukul D, Seth M, Schreiber T, Hanzel G, Khandelwal A, Cannon LA, Lalonde TA, Gurm HS.

J Interv Cardiol. 2017 Aug;30(4):291-300. doi: 10.1111/joic.12388. Epub 2017 May 22.

24.

Ileocolic junction resection in dogs and cats: 18 cases.

Fernandez Y, Seth M, Murgia D, Puig J.

Vet Q. 2017 Dec;37(1):175-181. doi: 10.1080/01652176.2017.1326186.

PMID:
28532340
26.

The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.

Sukul D, Seth M, Schreiber T, Khandelwal A, Cannon LA, LaLonde TA, Gurm HS.

Catheter Cardiovasc Interv. 2017 Nov 1;90(5):724-732. doi: 10.1002/ccd.27001. Epub 2017 Mar 17.

27.

Root Cause Analysis of Deaths in ST-Segment Elevation Myocardial Infarctions Treated With Primary PCI: What Can We Do Better?

El Sakr F, Kenaan M, Menees D, Seth M, Gurm HS.

J Invasive Cardiol. 2017 May;29(5):164-168. Epub 2017 Mar 15.

28.

Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality.

Parsh J, Seth M, Green J, Sutton NR, Chetcuti S, Dixon S, Grossman PM, Khandelwal A, Dupree JM, Gurm HS.

Catheter Cardiovasc Interv. 2017 May;89(6):966-973. doi: 10.1002/ccd.26917. Epub 2017 Feb 1.

29.

Standing balance in people with trans-tibial amputation due to vascular causes: A literature review.

Seth M, Lamberg E.

Prosthet Orthot Int. 2017 Aug;41(4):345-355. doi: 10.1177/0309364616683819. Epub 2017 Jan 9. Review.

PMID:
28067120
30.

Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.

Sukul D, Seth M, Dixon SR, Zainea M, Slocum NK, Pielsticker EJ, Gurm HS.

Catheter Cardiovasc Interv. 2017 Jul;90(1):94-101. doi: 10.1002/ccd.26781. Epub 2016 Sep 21.

31.

Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Sutton NR, Seth M, Ruwende C, Gurm HS.

J Am Coll Cardiol. 2016 Aug 30;68(9):895-904. doi: 10.1016/j.jacc.2016.05.085.

32.

Clinical leishmaniasis in dogs living in the UK.

Silvestrini P, Batchelor D, Allenspach K, Maunder C, Seth M, Mas A, Hill T, Serrano G, Roura X, Planellas M, German AJ, Pastor J.

J Small Anim Pract. 2016 Sep;57(9):453-8. doi: 10.1111/jsap.12503. Epub 2016 Jun 1.

PMID:
27251904
33.

The optimal definition of contrast-induced acute kidney injury for prediction of inpatient mortality in patients undergoing percutaneous coronary interventions.

Parsh J, Seth M, Briguori C, Grossman P, Solomon R, Gurm HS.

Am Heart J. 2016 May;175:160-7. doi: 10.1016/j.ahj.2016.02.013. Epub 2016 Feb 27.

PMID:
27179735
34.

Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.

Seth MK, Hussain ME, Pasha S, Fahim M.

Drug Des Devel Ther. 2016 Apr 20;10:1533-42. doi: 10.2147/DDDT.S77761. eCollection 2016.

35.

Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.

Khambatta S, Othman H, Seth M, Lalonde T, Rosman HS, Gurm HS, Mehta RH; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Investigators.

Cardiovasc Revasc Med. 2016 Jun;17(4):233-40. doi: 10.1016/j.carrev.2016.02.014. Epub 2016 Feb 27.

PMID:
26994504
36.

Acquired Fanconi-like syndrome cases associated with dried chicken and duck meat ingestion.

Sharman M, Seth M, Lam A, Kent A, Smith V, Carmichael N.

Vet Rec. 2016 Feb 20;178(8):196. doi: 10.1136/vr.i968. No abstract available.

PMID:
26893338
37.

Impact of Contrast Dose Reduction on Incidence of Acute Kidney Injury (AKI) Among Patients Undergoing PCI: A Modeling Study.

Gurm HS, Seth M, Mehran R, Cannon L, Grines CL, LaLonde T, Briguori C; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

J Invasive Cardiol. 2016 Apr;28(4):142-6. Epub 2016 Jan 15.

38.

Reply: The Gaps in Cardiac Rehabilitation Referral: The Elephant in the Room.

Aragam KG, Seth M, Gurm HS.

J Am Coll Cardiol. 2015 Dec 8;66(22):2574-5. doi: 10.1016/j.jacc.2015.09.064. No abstract available.

39.

Using simulation for teaching femoral arterial access: A multicentric collaboration.

Gurm HS, Sanz-Guerrero J, Johnson DD, Jensen A, Seth M, Chetcuti SJ, Lalonde T, Greenbaum A, Dixon SR, Shih A.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):376-80. doi: 10.1002/ccd.26256. Epub 2015 Oct 22.

PMID:
26489781
40.

Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.

Thomas MP, Parzynski CS, Curtis JP, Seth M, Nallamothu BK, Chan PS, Spertus JA, Patel MR, Bradley SM, Gurm HS.

PLoS One. 2015 Sep 17;10(9):e0138251. doi: 10.1371/journal.pone.0138251. eCollection 2015.

41.

The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Perdoncin E, Seth M, Dixon S, Cannon L, Khandelwal A, Riba A, David S, Wohns D, Gurm H.

Eur Heart J. 2016 Jun 21;37(24):1902-9. doi: 10.1093/eurheartj/ehv434. Epub 2015 Sep 15.

42.

If not now, when? Prescription of evidence-based medical therapy prior to hospital discharge increases utilization at 6 months in patients with symptomatic peripheral artery disease.

Renard BM, Seth M, Share D, Aronow HD, Laveroni EW, De Gregorio M, Hans SS, Henke PK, Gurm HS, Grossman PM.

Vasc Med. 2015 Dec;20(6):544-50. doi: 10.1177/1358863X15599249. Epub 2015 Aug 31.

PMID:
26324153
43.

Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions.

Parsh J, Seth M, Aronow H, Dixon S, Heung M, Mehran R, Gurm HS.

J Am Coll Cardiol. 2015 Jun 30;65(25):2714-23. doi: 10.1016/j.jacc.2015.04.037.

44.

Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions.

Kooiman J, Seth M, Nallamothu BK, Heung M, Humes D, Gurm HS.

Circ Cardiovasc Interv. 2015 Jun;8(6):e002212. doi: 10.1161/CIRCINTERVENTIONS.114.002212.

PMID:
26047992
45.

Radial PCI and the obesity paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

McDonagh JR, Seth M, LaLonde TA, Khandewal AK, Wohns DH, Dixon SR, Gurm HS.

Catheter Cardiovasc Interv. 2016 Feb 1;87(2):211-9. doi: 10.1002/ccd.26015. Epub 2015 May 22.

PMID:
26010906
46.

Underutilization of Radial Access in Patients Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Howe MJ, Seth M, Riba A, Hanzel G, Zainea M, Gurm HS.

Circ Cardiovasc Interv. 2015 May;8(5). pii: e002036. doi: 10.1161/CIRCINTERVENTIONS.114.002036.

PMID:
25922417
47.

Contemporary Use of Ticagrelor in Interventional Practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium).

Karve AM, Seth M, Sharma M, LaLonde T, Dixon S, Wohns D, Gurm HS.

Am J Cardiol. 2015 Jun 1;115(11):1502-6. doi: 10.1016/j.amjcard.2015.02.049. Epub 2015 Mar 12.

PMID:
25846767
48.

Use of a heart team in decision-making for patients with complex coronary disease at hospitals in Michigan prior to guideline endorsement.

Bruckel JT, Gurm HS, Seth M, Prager RL, Jensen A, Nallamothu BK.

PLoS One. 2014 Nov 21;9(11):e113241. doi: 10.1371/journal.pone.0113241. eCollection 2014.

49.

Daylight savings time and myocardial infarction.

Sandhu A, Seth M, Gurm HS.

Open Heart. 2014 Mar 28;1(1):e000019. doi: 10.1136/openhrt-2013-000019. eCollection 2014.

50.

Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.

Othman H, Khambatta S, Seth M, Lalonde TA, Rosman HS, Gurm HS, Mehta RH.

Am Heart J. 2014 Oct;168(4):552-9. doi: 10.1016/j.ahj.2014.07.012. Epub 2014 Jul 25.

PMID:
25262266

Supplemental Content

Support Center